首页> 外文期刊>Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology >The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
【24h】

The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.

机译:未经治疗的帕金森氏病(PD)中睡眠功能障碍的范围和性质。使用帕金森氏病睡眠量表和选择性多导睡眠监测仪进行的对照临床研究。

获取原文
获取原文并翻译 | 示例
           

摘要

In this study we have explored the nature and range of sleep dysfunction that occurs in untreated Parkinson's disease (PD) comparing data obtained from the use of the Parkinson's disease sleep scale (PDSS) in an untreated PD patient group compared to advanced PD and healthy controls. 25 untreated (drug-naive, DNPD) PD patients (mean age 66.9 years, range 53-80, 18 males) completed the validated Parkinson's disease sleep scale (PDSS), mean duration of PD was 2.1 years (1-10, up to 4 years in all except one patient with tremulous PD reporting tremor duration of 10 years) and mean Hoehn and Yahr score 1.9 (1-3). Data were compared to 34 advanced PD (mean age 70.2 years, range 51-88, 23 male), mean duration of PD 11 years (range 4-22), mean Hoehn and Yahr score 3.4 (3-5) and PDSS data obtained from 131 healthy controls (mean age 66.6 years, range 50-93, 56 males). Total PDSS scores and PDSS sub-items, except PDSS item 2, were highly significantly different (p<0.001) between DNPD, advanced PD and controls. Controls reported higher mean PDSS scores than both groups of patients, and advanced cases reported lower (mean+/-S.D.) PDSS scores (86.95+/-20.78) than drug-naive (105.72+/-21.5) (p<0.001). Logistic regression analysis showed that items PDSS8 (nocturia), PDSS11 (cramps), PDSS12 (dystonia), PDSS13 (tremor), and PDSS15 (daytime somnolence) were significantly impaired in DNPD compared to controls while PDSS7 (nighttime hallucinations) additionally separated advanced PD from DNPD. In a subgroup of 11 advanced PD cases (mean age 62 years, range=49-84 years, mean Hoehn and Yahr score 2.5, range=1-3) with high Epworth Sleepiness Scale (ESS) scores (mean 14.5), low item 15 PDSS score (mean 4.7) and complaints of severe daytime sleepiness, underwent detailed overnight polysomnography (PSG) studies, all showing abnormal sleep patterns. We conclude that nocturia, nighttime cramps, dystonia, tremor and daytime somnolence seem to be the important nocturnal disabilities in DNPD and some of these symptoms may be reminiscent of "off" period related symptoms even though patients are untreated. Furthermore, polysomnography in "sleepy" PD patients may help diagnose unrecognised conditions such as periodic limb movement of sleep (PLMS), obstructive sleep apnoea (OSA) and REM Sleep Behaviour Disorder.
机译:在这项研究中,我们比较了未经治疗的帕金森氏病(PD)患者组与未经治疗的帕金森氏病(PD)和健康对照组相比,使用帕金森氏病睡眠量表(PDSS)获得的数据,探讨了睡眠障碍的性质和范围。 25名未经治疗(未经药物治疗,DNPD)的PD患者(平均年龄66.9岁,范围53-80,男性18位)完成了验证的帕金森氏病睡眠量表(PDSS),PD的平均持续时间为2.1年(1-10岁,直至除一名患有震颤性PD的震颤持续时间为10年且平均Hoehn和Yahr评分为1.9(1-3)的患者外,全部为4年。将数据与34位晚期PD(平均年龄70.2岁,范围51-88,男性23位),PD的平均病程11年(范围4-22),Hoehn和Yahr平均得分3.4(3-5)以及获得的PDSS数据进行比较来自131位健康对照者(平均年龄66.6岁,范围50-93,男性56位)。除PDSS项目2外,PDPD的总得分和PDSS子项目在DNPD,高级PD和对照组之间有显着差异(p <0.001)。对照组的平均PDSS评分高于两组患者,晚期病例的PDSS评分(86.95 +/- 20.78)低于未接受过药物治疗的患者(105.72 +/- 21.5)(p <0.001)。 Logistic回归分析显示,与对照组相比,DNPD中的PDSS8(夜尿症),PDSS11(痉挛),PDSS12(肌张力障碍),PDSS13(震颤)和PDSS15(白天嗜睡)受到严重损害,而PDSS7(夜间幻觉)另外分离了晚期PD来自DNPD。在11例晚期PD患者中(平均年龄62岁,范围= 49-84岁,平均Hoehn和Yahr得分2.5,范围= 1-3),其爱泼华嗜睡量表(ESS)得分高(平均值14.5),低15例PDSS评分(平均4.7)和严重的白天嗜睡的抱怨,进行了详细的夜间多导睡眠图(PSG)研究,所有研究均显示异常的睡眠模式。我们得出结论,夜尿症,夜间痉挛,肌张力障碍,震颤和白天嗜睡似乎是DNPD中重要的夜间障碍,即使未经治疗,这些症状中的某些也可能让人联想到“休养期”相关症状。此外,“困” PD患者的多导睡眠图可以帮助诊断无法识别的疾病,例如周期性的肢体睡眠运动(PLMS),阻塞性睡眠呼吸暂停(OSA)和REM睡眠行为障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号